GLP-1s work in a number of ways to bring on weight loss, but their effect on reducing appetite is the major benefit of semaglutide when treating obesity, Kushner says
En estudios recientes, Tirzepatida ha mostrado ser efectivo en reducir hasta un 25% del peso corporal inicial en ciertos pacientes
R., & Muntean, C
Clinical trial results, side effects, dosing, and cost analysis of these GLP-1
The World Health Organization contextualizes being overweight as a condition of excessive fat deposits, and a diagnosis of obesity as a chronic complex disease defined by excessive fat deposits that can impair health, adding, obesity can lead to increased risk of type 2 diabetes and heart disease, it can affect bone health and reproduction, it increases the risk of certain cancers. While the benefits of Ozempic have been innovative in the treatment of obesity as a disease, its gained more attention as a vanity drug for its shrinking effects on celebrities and people using it as a get-skinny-quick tool for slimming down a few sizes
%20(1).png)
